Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 390,001 | 464,136 | 434,215 | 517,943 | 596,584 |
| Marketable Securities | 1,338,245 | 1,392,877 | 1,362,017 | 1,337,740 | 1,376,635 |
| Receivables | 491,575 | 498,273 | 494,645 | 432,302 | 450,324 |
| Inventories | 776,600 | 752,937 | 719,316 | 685,850 | 657,130 |
| Other current assets | 19,804 | 48,191 | 23,604 | 19,122 | 38,490 |
| TOTAL | $3,138,866 | $3,277,252 | $3,157,976 | $3,140,155 | $3,249,697 |
| Non-Current Assets | |||||
| PPE Net | 514,013 | 506,454 | 498,612 | 461,112 | 471,321 |
| Investments And Advances | 7,311,135 | 8,878,514 | 8,830,892 | 7,459,169 | 8,088,002 |
| Intangibles | 740,229 | 735,585 | 738,635 | 724,665 | 587,070 |
| Other Non-Current Assets | 273,986 | 269,607 | 275,551 | 273,361 | 286,037 |
| TOTAL | $8,839,363 | $10,390,160 | $10,343,690 | $8,918,307 | $9,432,430 |
| Total Assets | $11,978,230 | $13,667,410 | $13,501,670 | $12,058,460 | $12,682,130 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 476 | 519 | 465 | 448 | N/A |
| Accounts payable and accrued liabilities | 149,535 | 160,979 | 135,041 | 142,746 | 158,259 |
| Accrued Expenses | 154,704 | 173,913 | 194,790 | 192,460 | 180,631 |
| Other current liabilities | 166,243 | 167,196 | 169,648 | 171,706 | 212,715 |
| TOTAL | $581,982 | $589,623 | $568,708 | $570,677 | $613,714 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,198,384 | 1,198,005 | 1,197,716 | 1,197,272 | 1,196,943 |
| aiOther Non-Current Liabilities | 349,143 | 346,289 | 349,509 | 352,302 | 335,344 |
| TOTAL | $2,949,354 | $3,314,075 | $3,317,706 | $3,034,180 | $3,145,815 |
| Total Liabilities | $3,531,336 | $3,903,698 | $3,886,414 | $3,604,857 | $3,759,529 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,076 | 29,609 | 29,596 | 29,824 | 29,698 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | 8,804,664 | 9,966,959 | 9,898,203 | 9,046,530 | 9,210,457 |
| Other shareholders' equity | -372,646 | -408,648 | -466,408 | -845,475 | -533,726 |
| TOTAL | $8,446,893 | $9,763,716 | $9,615,252 | $8,453,605 | $8,922,597 |
| Total Liabilities And Equity | $11,978,229 | $13,667,414 | $13,501,666 | $12,058,462 | $12,682,126 |